Symptom Network Analysis in Patients Undergoing Chemotherapy for Colorectal Cancer: A Cross-Sectional Study.
단면연구
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
261 patients with CRC receiving chemotherapy across five tertiary care hospitals in Shanghai, selected through convenience sampling.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] This study is among the first to apply network analysis to chemotherapy-related symptom interactions and potential mechanisms in CRC, highlighting central targets for intervention. These findings may inform more precise and efficient symptom management approaches in oncology care.
[OBJECTIVE] This study aimed to construct a symptom network in patients diagnosed with colorectal cancer (CRC) undergoing chemotherapy, thereby providing a theoretical framework for optimizing symptom
- 연구 설계 cross-sectional
APA
Xie R, Gu XX, Wang Y (2025). Symptom Network Analysis in Patients Undergoing Chemotherapy for Colorectal Cancer: A Cross-Sectional Study.. Cancer management and research, 17, 3073-3085. https://doi.org/10.2147/CMAR.S558889
MLA
Xie R, et al.. "Symptom Network Analysis in Patients Undergoing Chemotherapy for Colorectal Cancer: A Cross-Sectional Study.." Cancer management and research, vol. 17, 2025, pp. 3073-3085.
PMID
41393251
Abstract
[OBJECTIVE] This study aimed to construct a symptom network in patients diagnosed with colorectal cancer (CRC) undergoing chemotherapy, thereby providing a theoretical framework for optimizing symptom management strategies.
[METHODS] A cross-sectional survey was conducted among 261 patients with CRC receiving chemotherapy across five tertiary care hospitals in Shanghai, selected through convenience sampling. Network analysis was applied to construct the symptom network and to determine centrality indices, including strength centrality. Model accuracy and stability were evaluated using nonparametric bootstrapping techniques.
[RESULTS] Symptom prevalence ranged from 5.4% to 85.8%, with severity scores ranging from 0.51±1.44 to 4.83±3.23. Fatigue was associated with the highest severity score. Depression ( = 2.188), nausea ( = 1.290), and anorexia ( = 1.223) demonstrated the highest strength centrality values. The constructed network model exhibited high accuracy and stability, as indicated by narrow confidence intervals and Correlation Stability (CS) coefficients exceeding 0.25.
[CONCLUSION] This study is among the first to apply network analysis to chemotherapy-related symptom interactions and potential mechanisms in CRC, highlighting central targets for intervention. These findings may inform more precise and efficient symptom management approaches in oncology care.
[METHODS] A cross-sectional survey was conducted among 261 patients with CRC receiving chemotherapy across five tertiary care hospitals in Shanghai, selected through convenience sampling. Network analysis was applied to construct the symptom network and to determine centrality indices, including strength centrality. Model accuracy and stability were evaluated using nonparametric bootstrapping techniques.
[RESULTS] Symptom prevalence ranged from 5.4% to 85.8%, with severity scores ranging from 0.51±1.44 to 4.83±3.23. Fatigue was associated with the highest severity score. Depression ( = 2.188), nausea ( = 1.290), and anorexia ( = 1.223) demonstrated the highest strength centrality values. The constructed network model exhibited high accuracy and stability, as indicated by narrow confidence intervals and Correlation Stability (CS) coefficients exceeding 0.25.
[CONCLUSION] This study is among the first to apply network analysis to chemotherapy-related symptom interactions and potential mechanisms in CRC, highlighting central targets for intervention. These findings may inform more precise and efficient symptom management approaches in oncology care.
같은 제1저자의 인용 많은 논문 (5)
- Prediction of malignancy and metastasis of thyroid cancer by combined feature sets through advanced machine learning.
- HRCHY-CytoCommunity identifies hierarchical tissue organization in cell-type spatial maps.
- MUS81 inhibits cell proliferation and migration in breast cancer by promoting the expression of CDKN2A(p16).
- Homogentisic acid metabolism inhibits papillary thyroid carcinoma proliferation through ROS and p21-induced cell cycle arrest.
- Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.